Literature DB >> 28109916

Polyphenolic enriched extract of Cassia glauca Lamk, improves streptozotocin-induced type-1 diabetes linked with partial insulin resistance in rats.

V P Veerapur1, V Pratap2, B S Thippeswamy3, P Marietta2, Punit Bansal4, P V Kulkarni2, V H Kulkarni2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Traditionally Cassia glauca (CG) has been used to treat diabetes. AIM OF THE STUDY: The study was undertaken to evaluate anti-diabetic and antioxidant activity of polyphenolic enriched extract of CG in standardized streptozotocin (STZ)-induced diabetic rats.
MATERIALS AND METHODS: The effect of ethanol (CGE) and water (CGW) extracts of CG (200 and 400mg/kg) treatment were evaluated in STZ (50mg/kg, iv) induced diabetic rats. On 10th day, oral glucose tolerance test and degree of insulin resistance was calculated. On 13th day, insulin tolerance test was performed to know the peripheral utilization of glucose. On 15th day, blood glucose, lipid profiles and endogenous antioxidant levels were estimated. In addition, the effects on oral glucose/sucrose tolerance test in normal rats. Further, HPLC fingerprinting profile of CGE and simultaneous quantification of biomarkers were carried out.
RESULTS: Supplementation with CGE and CGW significantly reduced STZ-induced deleterious effects and improved glucose tolerance, and insulin tolerance. In addition, supplementation also decreased oxidative stress by improving endogenous antioxidant levels. Furthermore, administration significantly improves sucrose tolerance suggesting that extract possess inhibition of α-glucosidase enzyme. Further, HPLC studies revealed that CGE contains three bioactive polyphenolic compounds viz., rutin (0.10±0.01mg/g), luteolin-7-glucoside (0.06±0.01mg/g) and isorhoifolin (0.7±0.05mg/g).
CONCLUSION: Observed beneficial outcome of CG might be attributed to the presence of polyphenolic compounds and mediated by interacting with multiple targets of diabetes and oxidative stress. Taken together, this study provided the scientific evidence for the traditional use of CG.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Caesalpiniacea; Cassia glauca; Flavonoids; Insulin resistance; Streptozotocin; Type-1 diabetes; in vitro antioxidant

Mesh:

Substances:

Year:  2017        PMID: 28109916     DOI: 10.1016/j.jep.2017.01.025

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Gene ontology enrichment analysis of PPAR-γ modulators from Cassia glauca in diabetes mellitus.

Authors:  Shama G Ternikar; M B Patil; Ismail Pasha; Prarambh S R Dwivedi
Journal:  J Diabetes Metab Disord       Date:  2021-09-02

2.  Aldose reductase inhibitor form Cassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation.

Authors:  Samir M Osman; Nahla A Ayoub; Safaa A Hafez; Haitham A Ibrahim; Mohamed A El Raey; Soad Z El-Emam; Ahmed A Seada; Amr M Saadeldeen
Journal:  PLoS One       Date:  2020-10-16       Impact factor: 3.240

3.  Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats.

Authors:  Amir Abbas Momtazi-Borojeni; Mahmoud Reza Jaafari; Elham Abdollahi; Maciej Banach; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2021-08-30       Impact factor: 4.061

4.  Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics.

Authors:  Prarambh S R Dwivedi; Rajesh Patil; Pukar Khanal; Nilambari S Gurav; Vaishali D Murade; Dinesh P Hase; Mohan G Kalaskar; Muniappan Ayyanar; Rupesh V Chikhale; Shailendra S Gurav
Journal:  RSC Adv       Date:  2021-12-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.